CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
MONDAY 05 SEPTEMBER, 2016
PA2473
Improvements in risk stratification (RS): Beyond the pulmonary embolism severity index (PESI) score
Anabel Garcia Onieva (Valladolid, Spain), Anabel Garcia Onieva, Ana Maria Andrés Porras, Blanca De Vega Sánchez,
Águeda Herrero Perez, Sandra Isabel Llerena Butron
T-19 Session 392 12:50 - 14:40
Thematic Poster: Pulmonary hypertension and pulmonary embolism: from the bench to the
bedside
Chairs : Laura Price (London, United Kingdom), Alice Huertas (Paris, France), David Jiménez Castro (Madrid, Spain), Andrew Peacock
(Glasgow, United Kingdom)
PA2474
Spontaneous flow increase from implantable pump for intravenous treprostinil delivery
Frédéric Lador (Genève 14, Switzerland), Garance Kopp, Anne-Lise Hachulla, Stéphane Noble, Paola M. Soccal, Maurice
Beghetti, Frédéric Lador
PA2475
PA2476
PA2477
PA2478
PA2479
PA2480
PA2481
PA2482
PA2483
PA2484
PA2485
PA2486
PA2487
PSGR olfactory receptor: A new potential target in pulmonary arterial hypertension
Audrey Courboulin (Le Plessis-Robinson, France), Audrey Courboulin, Marceau Quatredeniers, Guenhaël Sanz, Sandra
Breuils-Bonnet, Matthieu Vocelle, Mathilde Lafond, Frédéric Perros, Sébastien Bonnet, Edit Pajot-Augy, Marc Humbert,
Sylvia Cohen-Kaminsky
Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Aaron Waxman (Boston, United States of America), Sergio Segrera, Alexander Opotowsky, Laurie Lawler, David Systrom,
Aaron Waxman
Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle
cells
ZHUOLI ZHANG (BEIJING, China), YONG FAN (BEIJING, China), Zhuoli Zhang, Lan Gao, Yong Fan, Yanjie Hao,
WEI Zhou
Pulmonary arterial hypertension associated with several mutations
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Adolfo Baloira, Diana Valverde
Neutrophil- to-lymphocyte ratio as a prognostic parameter in pulmonary arterial hypertension
Vasile Foris (Graz, Austria), Vasile Foris, Gabor Kovacs, Philipp Douschan, Alexander Avian, Andrea Olschewski, Horst
Olschewski
Diagnostic utility of the physical examination for pulmonary hypertension
Kevin Solverson (Calgary, Canada), Kevin Solverson, Daniel Vis, Micheal Braganza, Jeff Shaw, Luke Rannelli, Mitesh
Thakrar, Rhea Varughese, Naushad Hirani, Doug Helmersen, Jason Weatherald
Intravenous prostacyclin for pulmonary hypertension: Patient’s perspective on complications
Sara Tyebally (London, United Kingdom), Sara Tyebally, Ann Sturdy, Arif Khokhar, Lisa Parfitt, Carl Harries, Laura Price,
John Wort, Rafa Alonso, Kostas Dimopoulos, Michael Gatzoulis
Argon reduces the ET-1 induced increase of segmental PVR and the generation of lung edema
Annette Rieg (Aachen, Germany), Said Suleiman, Mark Coburn, Julia Krabbe, Rolf Rossaint, Christian Martin, Annette
Rieg
Role of survivin in experimental models of pulmonary arterial hypertension
ISABEL BLANCO (BARCELONA, Spain), Isabel Blanco, Elisabet Ferrer, Susana Maqueda, Tanja Paul, Neus Luque, Olga
Tura-Ceide, Victor Ivo Peinado, Joan Albert Barbera
Clinical manifestations and genetic background in Japanese patients with hereditary haemorrhagic telangiectasia
Kunihiko Yoshimura (Tokyo, Japan), Kunihiko Yoshimura, Takafumi Ito, Hiromi Aono
Inhaled INS1009 demonstrates localized pulmonary vasodilation activity
Zhili Li (Bridgewater, United States of America), Zhili Li, Richard Chapman, Vladimir Malinin, Michel Corboz, Adam
Plaunt, Charles Laurent, Han Yin, Dan Salvail, Walter Perkins
Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Mauro Lago, Sonia Prado-López, Adolfo Baloira, Rubén Varela-
Calviño, Diana Valverde
Centrilobular nodules are combined with lack of PFO and worse haemodynamic profile in IPAH patients
Monika Szturmowicz (Warsaw, Poland), Monika Szturmowicz, Aneta Kacprzak, Marcin Kurzyna, Barbara Burakowska,
Adam Torbicki
170 26.08.2016